A small clinical trial in ALS patients found that the Rozebalamin formulation consistently improved brain-muscle communication when given at very high doses (25 mg)
Schaub JA, AlAkwaa FM, McCown PJ et al (2023) SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth onset type 2 diabetes
Contraindication review: Your provider will specifically ask about thyroid cancer history, pancreatitis, and any gastrointestinal conditions that might affect tolerability or safety
00:06:49 Vickie Danaher And then either semaglutide products for obesity, so either the oral tablets or the injectable lead to about 26 or 27 pounds more weight loss than placebo
Discontinuing treatment without adhering to ongoing lifestyle changes may lead to weight regain, as observed in some scientific findings
J Diabetes Metab Disord 23 , 24112414 (2024)